Plain-English translation of NCT05885724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying biological markers in the blood of people with anorexia nervosa to understand the disease at a deeper level and find new ways to treat it. This study will compare blood samples and body composition measurements between adults with anorexia nervosa and healthy volunteers to identify proteins and immune factors that might be targeted by future treatments. The goal is to show that anorexia nervosa is a biological disease, not just something someone can control through willpower alone.
Anorexia nervosa is a serious eating disorder, but current treatments don't work well enough for many people. By identifying specific biological markers that drive the disease, researchers hope to develop more targeted, personalized treatments that go beyond traditional psychiatric care.
You likely qualify if…
You likely don't qualify if…
You will visit the research center where staff will draw blood samples to measure specific proteins and immune markers. You will also have body composition scans (DEXA) and a test to measure how your body uses energy. The study involves approximately 32 participants total — some with anorexia nervosa and some healthy volunteers matched by age and sex — and the visits are designed to take a few hours.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Switzerland